✦ LIBER ✦

Neutralising human recombinant antibodies to human cytomegalovirus glycoproteins gB and gH

✍ Scribed by Foroogh Nejatollahi; Samantha J Hodgetts; Pamela J Vallely; James P Burnie

Book ID: 114304167
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 253 KB
Volume: 34
Category: Article
ISSN: 0928-8244
DOI: 10.1016/s0928-8244(02)00400-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neutralising human recombinant antibodie

Neutralising human recombinant antibodies to human cytomegalovirus glycoproteins gB and gH

✍ Foroogh Nejatollahi; Samantha J Hodgetts; Pamela J Vallely; James P Burnie 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Use of recombinant glycoprotein antigens

Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy

✍ Maren Eggers; Klaus Radsak; Gisela Enders; Marko Reschke 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Development of neutralising human recomb

Development of neutralising human recombinant antibodies to pertussis toxin

✍ Peter Williamson; Ruth Matthews 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB

Development of neutralising human recomb

Development of neutralising human recombinant antibodies to pertussis toxin

✍ Peter Williamson; Ruth Matthews 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

UL74 of human cytomegalovirus reduces th

UL74 of human cytomegalovirus reduces the inhibitory effect of gH-specific and gB-specific antibodies

✍ Xiao Jing Jiang; Kerstin Laib Sampaio; Nicole Ettischer; York-Dieter Stierhof; G 📂 Article 📅 2011 🏛 Springer Vienna 🌐 English ⚖ 558 KB

Antibody response to human cytomegalovir

Antibody response to human cytomegalovirus (HCMV) glycoprotein B (gB) in AIDS patients with HCMV end-organ disease

✍ Alberola, Juan; Domínguez, Victoria; Cardeñoso, Laura; López-Aldeguer, Jose; Bla 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

Human cytomegalovirus (HCMV)-specific antibody responses in HIV-1 infected individuals either with or without HCMV end-organ disease were examined to determine the whether development of HCMV disease was associated with a particular deficit in the antibody response. Antiwhole HCMV, anti-glycoprotein